1-8 of 8
Annette von Drygalski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort

Jacqueline N. Poston, Cassandra Bryan, Annette von Drygalski, Kadhim Al Banaa, Jenny Y. Zhou, Aric Parnes, Evan C. Chen, Osman Khan, Patrick Ellsworth, Lorraine Cafuir, Christopher Walsh, Miguel A. Escobar, James F. Wu, Lynn M. Malec, Craig M. Kessler, Maissaa Janbain, Rebecca Kruse-Jarres
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5896–5905.
https://doi.org/10.1182/bloodadvances.2024013882
Published: 2024
Includes: Supplemental data
Journal Articles

Optimizing liver health before and after gene therapy for hemophilia A

Margaret V. Ragni, Henry Mead, Ype P. de Jong, Radoslaw Kaczmarek, Andrew D. Leavitt, Brian Long, Diane J. Nugent, Denise E. Sabatino, Sylvia Fong, Annette von Drygalski, Christopher E. Walsh, Bruce A. Luxon
Journal: Blood Advances
Blood Adv (2024) 8 (19): 5203–5212.
https://doi.org/10.1182/bloodadvances.2024013059
Published: 2024
Journal Articles

Evaluating the impact of a year-long external mentorship pilot program in classical hematology

Zoya Qureshy, Pooja Nair, Sara K. Vesely, Allison A. King, Alfred I. Lee, Nathan T. Connell, Annette von Drygalski, Ida Wong-Sefidan, Martina C. Murphy, Ronak H. Mistry, Rebecca L. Zon, Erin G. Reid, Josel Fritz, Soo J. Park
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4833–4844.
https://doi.org/10.1182/bloodadvances.2024013218
Published: 2024
Includes: Supplemental data
Journal Articles

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy

Clinical Trials & Observations
Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan U. Lattimore, Frank W. G. Leebeek, Wolfgang A. Miesbach, Michael Recht, Robert Gut, Ricardo Dolmetsch, Paul E. Monahan, Sandra Le Quellec, Steven W. Pipe
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5671–5679.
https://doi.org/10.1182/bloodadvances.2022008886
Published: 2023
Includes: Supplemental data
Journal Articles

An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice

Bilgimol Chumappumkal Joseph, Byron Y. Miyazawa, Charles T. Esmon, Mitchell J. Cohen, Annette von Drygalski, Laurent O. Mosnier
Journal: Blood Advances
Blood Adv (2022) 6 (3): 959–969.
https://doi.org/10.1182/bloodadvances.2021005257
Published: 2022
Includes: Supplemental data
Journal Articles

An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms

Annette von Drygalski, Vikas Bhat, Andrew J. Gale, Patricia M. Averell, Thomas J. Cramer, Darlene J. Elias, John H. Griffin, Laurent O. Mosnier
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3716–3727.
https://doi.org/10.1182/bloodadvances.2020001699
Published: 2020
Includes: Supplemental data
Journal Articles

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

Annette Von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W. G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3241–3247.
https://doi.org/10.1182/bloodadvances.2019000811
Published: 2019
Includes: Supplemental data
Journal Articles

A cross-sectional analysis of cardiovascular disease in the hemophilia population

Clinical Trials & Observations
Suman L. Sood, Dunlei Cheng, Margaret Ragni, Craig M. Kessler, Doris Quon, Amy D. Shapiro, Nigel S. Key, Marilyn J. Manco-Johnson, Adam Cuker, Christine Kempton, Tzu-Fei Wang, M. Elaine Eyster, Philip Kuriakose, Annette von Drygalski, Joan Cox Gill, Allison Wheeler, Peter Kouides, Miguel A. Escobar, Cindy Leissinger, Sarah Galdzicka, Marshall Corson, Crystal Watson, Barbara A. Konkle
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1325–1333.
https://doi.org/10.1182/bloodadvances.2018018226
Published: 2018